<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="brief-report">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Ann Lab Med</journal-id>
      <journal-id journal-id-type="iso-abbrev">Ann Lab Med</journal-id>
      <journal-id journal-id-type="publisher-id">ALM</journal-id>
      <journal-title-group>
        <journal-title>Annals of Laboratory Medicine</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">2234-3806</issn>
      <issn pub-type="epub">2234-3814</issn>
      <publisher>
        <publisher-name>The Korean Society for Laboratory Medicine</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">26709268</article-id>
      <article-id pub-id-type="pmc">4713854</article-id>
      <article-id pub-id-type="doi">10.3343/alm.2016.36.2.177</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Letter to the Editor</subject>
          <subj-group subj-group-type="subheading">
            <subject>Diagnostic Hematology</subject>
          </subj-group>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Clinical Utility of Bone Marrow Study in Gaucher Disease: A Case Report of Gaucher Disease Type 3 With Intractable Myoclonic Seizures</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Rim</surname>
            <given-names>John Hoon</given-names>
          </name>
          <degrees>M.D.</degrees>
          <xref ref-type="aff" rid="A1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Baik</surname>
            <given-names>Minyoul</given-names>
          </name>
          <degrees>M.D.</degrees>
          <xref ref-type="aff" rid="A2">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Yoon</surname>
            <given-names>Sun Och</given-names>
          </name>
          <degrees>M.D.</degrees>
          <xref ref-type="aff" rid="A3">3</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Heo</surname>
            <given-names>Kyoung</given-names>
          </name>
          <degrees>M.D.</degrees>
          <xref ref-type="aff" rid="A2">2</xref>
        </contrib>
        <contrib contrib-type="author" corresp="yes">
          <name>
            <surname>Song</surname>
            <given-names>Jaewoo</given-names>
          </name>
          <degrees>M.D.</degrees>
          <xref ref-type="aff" rid="A1">1</xref>
        </contrib>
      </contrib-group>
      <aff id="A1"><label>1</label>Department of Laboratory Medicine, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea.</aff>
      <aff id="A2"><label>2</label>Department of Neurology, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea.</aff>
      <aff id="A3"><label>3</label>Department of Pathology, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea.</aff>
      <author-notes>
        <corresp>Corresponding author: Jaewoo Song. Department of Laboratory Medicine, Severance Hospital, Yonsei University College of Medicine, 50-1 Yonsei-ro, Seodaemun-gu, Seoul 03722, Korea. Tel: +82-2-2228-2445, Fax: +82-2-364-1583, <email>labdx@yuhs.ac</email></corresp>
      </author-notes>
      <pub-date pub-type="ppub">
        <month>3</month>
        <year>2016</year>
      </pub-date>
      <pub-date pub-type="epub">
        <day>18</day>
        <month>12</month>
        <year>2015</year>
      </pub-date>
      <volume>36</volume>
      <issue>2</issue>
      <fpage>177</fpage>
      <lpage>179</lpage>
      <history>
        <date date-type="received">
          <day>15</day>
          <month>7</month>
          <year>2015</year>
        </date>
        <date date-type="rev-recd">
          <day>17</day>
          <month>9</month>
          <year>2015</year>
        </date>
        <date date-type="accepted">
          <day>10</day>
          <month>11</month>
          <year>2015</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9; The Korean Society for Laboratory Medicine.</copyright-statement>
        <copyright-year>2016</copyright-year>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc/3.0/">
          <license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc/3.0/">http://creativecommons.org/licenses/by-nc/3.0/</ext-link>) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
        </license>
      </permissions>
    </article-meta>
  </front>
  <body>
    <p>Dear Editor,</p>
    <p>Gaucher disease (GD) is the most common lysosomal storage disease, characterized by glucosylceramide accumulation in macrophages owing to inherited glucocerebrosidase deficiency caused by <italic>GBA1</italic> mutation [<xref rid="B1" ref-type="bibr">1</xref>]. Clinical manifestations include thrombocytopenia, hepatosplenomegaly, bone pain, osteopenia, dyspnea, and seizure, depending on the organ involved [<xref rid="B2" ref-type="bibr">2</xref>]. Among these, neurologic involvement plays a crucial role in the classification of the following three subtypes: GD types 1, 2, and 3, called non-neuronopathic, acute neuronopathic, and chronic neuronopathic types, respectively [<xref rid="B1" ref-type="bibr">1</xref><xref rid="B2" ref-type="bibr">2</xref>]. &#x3B2;-glucocerebrosidase activity in peripheral leukocyte is considered the confirmatory diagnostic indicator of GD [<xref rid="B2" ref-type="bibr">2</xref>]. Bone marrow (BM) study to detect Gaucher cells (GCs) with the classical "wrinkled tissue paper" appearance has not been routinely recommended because of procedural risks and false-positive results [<xref rid="B3" ref-type="bibr">3</xref>]. We present a patient with recurrent seizures as a sole symptom who was correctly diagnosed as having GD type 3 through a BM study.</p>
    <p>A 31-yr-old woman with recurrent seizures was referred to our hospital. She experienced the first seizure attack at the age of 23 yr. Despite constant antiepileptic medications at the outpatient clinic, she had drug-resistant myoclonic seizures, intermittently evolving to generalized tonic-clonic seizures, which required 11 hospital admissions during the last three years. The initial complete blood count showed no specific findings other than mild leukopenia, with the following values: hemoglobin, 11.9 g/dL; platelets, 162&#xD7;10<sup>9</sup>/L; and leukocytes, 3.32&#xD7;10<sup>9</sup>/L, with normal differential counts (<xref ref-type="fig" rid="F1">Fig. 1A</xref>). Physical examination and abdominal ultrasonography revealed no evidence of splenomegaly or hepatomegaly. Drug-induced leukopenia related with long-term use of antiepileptic medications was initially suspected, but the patient showed mild leukopenia during the recent eight weeks, with leukocyte levels ranging from 3.00&#xD7;10<sup>9</sup>/L to 3.59&#xD7;10<sup>9</sup>/L. Accordingly, the attending physician performed a BM study.</p>
    <p>In hypocellular marrow with normal distribution, GCs accounted for 17.5% of all nucleated cells on the aspiration smear (<xref ref-type="fig" rid="F1">Fig. 1B</xref>). Of the GCs, 10.5% showed atypical vacuolations, while the others showed typical fibrillary cytoplasm with an eccentrically placed nucleus (<xref ref-type="fig" rid="F1">Fig. 1C</xref>). Despite the consistent BM biopsy findings of GCs (<xref ref-type="fig" rid="F1">Fig. 1D</xref>), reticulin staining showed no evidence of abnormal reticulin fibrosis (i.e., grade 0). In addition, &#x3B2;-glucocerebrosidase activity test revealed 0.6 nmol/hr/mg protein, which is much lower than the reference limit of 6.0 nmol/hr/mg protein. <italic>GBA1</italic> sequencing to confirm the diagnosis revealed two point mutations (i.e., N188S and R257Q), both previously reported as the cause of GD. Under the diagnosis of GD type 3, the patient was given enzyme replacement therapy with imiglucerase (Cerezyme, Genzyme Corporation, Cambridge, MA, USA), and her leukocyte count returned to normal. However, the neurological symptoms did not alleviate, coinciding with the fact that imiglucerase is well known to be unable to penetrate the blood-brain barrier.</p>
    <p>Owing to the phenotypic variability of GD, which might hinder prompt diagnosis or timely clinical impression, several guidelines for optimal diagnostic algorithm and evaluation steps have been suggested [<xref rid="B4" ref-type="bibr">4</xref><xref rid="B5" ref-type="bibr">5</xref>]. Regardless of GD subtypes, hepatosplenomegaly and thrombocytopenia were considered as the most common clinical features. Therefore, hematologic aspects of GD have been emphasized for the early diagnosis of preventable complications [<xref rid="B2" ref-type="bibr">2</xref><xref rid="B6" ref-type="bibr">6</xref>]. Even though the clinical utility of BM study in GD is controversial, GCs detected in BM have been the most important diagnostic indicator in our patient. The long seizure history was explained on the basis of the BM finding, which suggests the reappraisal of the clinical utility of BM study in GD despite professionally appropriate evaluation.</p>
    <p>Atypical GCs in BM of type 1 GD were evaluated by using the cytomorphological approach in a recent study, in which seven types, including foamy cytoplasm, multinuclearity, erythrophagocytosis, and cytoplasmic projections, were described [<xref rid="B7" ref-type="bibr">7</xref>]. The authors suggested that foamy transformation of GCs might be associated with an abnormal storage pattern triggered by an external factor, possibly seizure attacks in this case. Another recent study focused on the differential clinical utilities of BM biopsy and aspiration to detect the presence of GCs [<xref rid="B8" ref-type="bibr">8</xref>]. Although biopsy seemed more sensitive to GCs, our patient showed a comparable percentage of GCs in aspiration and biopsy, which might be related to the absence of abnormal reticulin fibrosis in this case.</p>
    <p>In conclusion, we report a GD patient with recurrent seizures as the single classical symptom, in whom GC detected in BM indicated the correct diagnosis of GD. Our case might emphasize the clinical utility of BM study for GD, especially in cases of unexplained seizures without prominent hematologic abnormalities. Further studies to investigate the roles of BM study for GD for monitoring enzyme replacement therapy response are expected.</p>
  </body>
  <back>
    <fn-group>
      <fn fn-type="conflict">
        <p><bold>Authors' Disclosures of Potential Conflicts of Interest:</bold> No potential conflicts of interest relevant to this article were reported.</p>
      </fn>
    </fn-group>
    <ref-list>
      <ref id="B1">
        <label>1</label>
        <element-citation publication-type="journal">
          <collab>Gaucher disease</collab>
          <article-title>Current issues in diagnosis and treatment. NIH Technology Assessment Panel on Gaucher Disease</article-title>
          <source>JAMA</source>
          <year>1996</year>
          <volume>275</volume>
          <fpage>548</fpage>
          <lpage>553</lpage>
          <pub-id pub-id-type="pmid">8606477</pub-id>
        </element-citation>
      </ref>
      <ref id="B2">
        <label>2</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Thomas</surname>
              <given-names>AS</given-names>
            </name>
            <name>
              <surname>Mehta</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Hughes</surname>
              <given-names>DA</given-names>
            </name>
          </person-group>
          <article-title>Gaucher disease: haematological presentations and complications</article-title>
          <source>Br J Haematol</source>
          <year>2014</year>
          <volume>165</volume>
          <fpage>427</fpage>
          <lpage>440</lpage>
          <pub-id pub-id-type="pmid">24588457</pub-id>
        </element-citation>
      </ref>
      <ref id="B3">
        <label>3</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Mistry</surname>
              <given-names>PK</given-names>
            </name>
            <name>
              <surname>Cappellini</surname>
              <given-names>MD</given-names>
            </name>
            <name>
              <surname>Lukina</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Ozsan</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Mach Pascual</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Rosenbaum</surname>
              <given-names>H</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>A reappraisal of Gaucher disease-diagnosis and disease management algorithms</article-title>
          <source>Am J Hematol</source>
          <year>2011</year>
          <volume>86</volume>
          <fpage>110</fpage>
          <lpage>115</lpage>
          <pub-id pub-id-type="pmid">21080341</pub-id>
        </element-citation>
      </ref>
      <ref id="B4">
        <label>4</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Mistry</surname>
              <given-names>PK</given-names>
            </name>
            <name>
              <surname>Sadan</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Yang</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Yee</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Yang</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Consequences of diagnostic delays in type 1 Gaucher disease: the need for greater awareness among hematologists-oncologists and an opportunity for early diagnosis and intervention</article-title>
          <source>Am J Hematol</source>
          <year>2007</year>
          <volume>82</volume>
          <fpage>697</fpage>
          <lpage>701</lpage>
          <pub-id pub-id-type="pmid">17492645</pub-id>
        </element-citation>
      </ref>
      <ref id="B5">
        <label>5</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Di Rocco</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Andria</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Deodato</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Giona</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Micalizzi</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Pession</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Early diagnosis of Gaucher disease in pediatric patients: proposal for a diagnostic algorithm</article-title>
          <source>Pediatr Blood Cancer</source>
          <year>2014</year>
          <volume>61</volume>
          <fpage>1905</fpage>
          <lpage>1909</lpage>
          <pub-id pub-id-type="pmid">25131373</pub-id>
        </element-citation>
      </ref>
      <ref id="B6">
        <label>6</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Thomas</surname>
              <given-names>AS</given-names>
            </name>
            <name>
              <surname>Mehta</surname>
              <given-names>AB</given-names>
            </name>
            <name>
              <surname>Hughes</surname>
              <given-names>DA</given-names>
            </name>
          </person-group>
          <article-title>Diagnosing Gaucher disease: an on-going need for increased awareness amongst haematologists</article-title>
          <source>Blood Cells Mol Dis</source>
          <year>2013</year>
          <volume>50</volume>
          <fpage>212</fpage>
          <lpage>217</lpage>
          <pub-id pub-id-type="pmid">23219328</pub-id>
        </element-citation>
      </ref>
      <ref id="B7">
        <label>7</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Markuszewska-Kuczynska</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Klimkowska</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Regenthal</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Bulanda</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>K&#xE4;mpe Bj&#xF6;rkvall</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Machaczka</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Atypical cytomorphology of Gaucher cells is frequently seen in bone marrow smears from untreated patients with Gaucher disease type 1</article-title>
          <source>Folia Histochem Cytobiol</source>
          <year>2015</year>
          <volume>53</volume>
          <fpage>62</fpage>
          <lpage>69</lpage>
          <pub-id pub-id-type="pmid">25736845</pub-id>
        </element-citation>
      </ref>
      <ref id="B8">
        <label>8</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Machaczka</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Markuszewska-Kuczynska</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Regenthal</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Jurczyszyn</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Galazka</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Wahlin</surname>
              <given-names>BE</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Clinical utility of different bone marrow examination methods in the diagnosis of adults with sporadic Gaucher disease type 1</article-title>
          <source>Pol Arch Med Wewn</source>
          <year>2014</year>
          <volume>124</volume>
          <fpage>587</fpage>
          <lpage>592</lpage>
          <pub-id pub-id-type="pmid">25188399</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
  <floats-group>
    <fig id="F1" orientation="portrait" position="float">
      <label>Fig. 1</label>
      <caption>
        <title>Microscopic examination of the patient's (A) peripheral blood (&#xD7;400, Wright-Giemsa stain) and (B) bone marrow aspiration (&#xD7;400, Wright-Giemsa stain). (C) Atypical Gaucher cell with vacuolations and typical Gaucher cell with a "wrinkled tissue pattern" on bone marrow aspirate smear (&#xD7;1,000, Wright-Giemsa stain). (D) Bone marrow biopsy specimen presenting with several Gaucher cells (&#xD7;400, Hematoxylin &amp; Eosin stain).</title>
      </caption>
      <graphic xlink:href="alm-36-177-g001"/>
    </fig>
  </floats-group>
</article>
</pmc-articleset>
